484
Participants
Start Date
March 31, 2014
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
210 mg brodalumab
210 mg brodalumab administered via subcutaneous injection.
140 mg brodalumab
140 mg brodalumab administered via subcutaneous injection.
Placebo
Placebo administered via subcutaneous injection until week 24.
Research Site, Riga
Research Site, Riga
Research Site, Riga
Research Site, Riga
Research Site, Budapest
Research Site, Budapest
Research Site, Eger
Research Site, Nyíregyháza
Research Site, Szolnok
Research Site, Székesfehérvár
Research Site, Szombathely
Research Site, Athens
Research Site, Athens
Research Site, Rochester
Research Site, Athens
Research Site, Wheaton
Research Site, Mexicali
Research Site, Chesapeake
Research Site, Lübeck
Research Site, Hanover
Research Site, Hildesheim
Research Site, Bordeaux
Research Site, Tampa
Research Site, Tampa
Research Site, St. Petersburg
Research Site, Sarasota
Research Site, Larissa
Research Site, Paducah
Research Site, Nantes
Research Site, Guadalajara
Research Site, Guadalajara
Research Site, Guadalajara
Research Site, Lansing
Research Site, Battle Creek
Research Site, Grand Rapids
Research Site, Reims
Research Site, Thessaloniki
Research Site, Lille
Research Site, Frankfurt
Research Site, Chicago
Research Site, St Louis
Research Site, Lyon Cédex 3
Research Site, Baton Rouge
Research Site, Little Rock
Research Site, Oklahoma City
Research Site, Tulsa
Research Site, Paris
Research Site, Dallas
Research Site, Dallas
Research Site, Paris
Research Site, Waco
Research Site, Ciudad Obregón
Research Site, Peoria
Research Site, Las Vegas
Research Site, Cypress
Research Site, La Jolla
Research Site, Palm Desert
Research Site, Victorville
Research Site, Hemet
Research Site, Huntington Beach
Research Site, Le Kremlin-Bicêtre
Research Site, Palo Alto
Research Site, Mérida
Research Site, Seattle
Research Site, Moscow
Research Site, Petrozavodsk
Research Site, Saint Petersburg
Research Site, Smolensk
Research Site, Kursk
Research Site, Voronezh
Research Site, Saratov
Research Site, Chelyabinsk
Research Site, Yekaterinburg
Research Site, Kemerovo
Research Site, Boston
Research Site, Calgary
Research Site, Victoria
Research Site, Winnipeg
Research Site, St. John's
Research Site, St. John's
Research Site, Waterloo
Research Site, Québec
Research Site, Québec
Research Site, Trois-Rivières
Research Site, Leipzig
Research Site, Gdansk
Research Site, Gdynia
Research Site, Grodzisk Mazowiecki
Research Site, Katowice
Research Site, Lodz
Research Site, Lodz
Research Site, Lublin
Research Site, Poznan
Research Site, Stalowa Wola
Research Site, Świdnik
Research Site, Warsaw
Research Site, Warsaw
Research Site, Warsaw
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Wroclaw
Research Site, Wroclaw
Research Site, Wroclaw
Bausch Health Americas, Inc.
INDUSTRY